Oral Herpes Simplex is a viral infection of the oral and perioral tissues caused by herpes simplex virus type 1 (HSV-1), characterized by clusters of painful vesicles affecting the lips, gingiva, palate, and surrounding oral mucosa. It ranks among the most prevalent orofacial viral infections worldwide, with most adults carrying latent HSV-1 in the trigeminal ganglion following childhood exposure.

Clinical Presentation

Primary herpetic gingivostomatitis — the initial symptomatic episode — typically occurs in young children and presents with fever, malaise, cervical lymphadenopathy, and widespread oral vesicles that rupture into shallow, erythematous ulcers covering the oral mucosa and attached gingiva. Adults experiencing primary infection often have more pronounced systemic symptoms. After resolution, the virus enters a dormant state and may reactivate as herpes labialis (cold sores), which characteristically emerge at the vermilion border of the lip rather than on movable, non-keratinized mucosa.

Signs and Symptoms

• Tingling, itching, or burning prodrome that precedes visible lesion formation
• Clusters of small, fluid-filled vesicles that rupture and crust over within days
• Pain that interferes with eating, speaking, and oral hygiene maintenance
• Diffuse erythema and edema of the attached gingiva during primary infection
• Regional lymphadenopathy and low-grade fever in primary herpetic episodes

Dental Relevance and Differential Diagnosis

Accurately distinguishing oral herpes simplex from recurrent aphthous ulcers is clinically essential: herpetic lesions preferentially affect keratinized tissue such as the hard palate and attached gingiva, whereas aphthous ulcers arise on non-keratinized movable mucosa like the buccal mucosa and floor of the mouth. This distinction directly influences management decisions and prevents misdiagnosis. Because HSV-1 can be transmitted through direct contact with active lesions or through asymptomatic viral shedding, dental providers must maintain standard infection-control precautions throughout all procedures, particularly those involving soft-tissue manipulation such as periodontal scaling and root planing.

Antiviral agents — most commonly acyclovir or valacyclovir — are most effective when initiated during the prodromal phase and can significantly reduce lesion duration and severity. Patients who experience frequent recurrences or who are immunocompromised may be candidates for daily suppressive antiviral therapy.

Early recognition of oral herpes simplex and careful differentiation from other ulcerative oral conditions enables clinicians to recommend timely antiviral treatment, apply appropriate infection controls, and guide patients on identifying and minimizing personal reactivation triggers.